$BYAH

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH

GlobeNewswire Inc. · 8/1/2026, 6:58:00 PM

Rosen Law Firm has filed class action lawsuits against Park Ha Biological Technology Co., Ltd. (PHH, BYAH) for securities fraud involving false statements and undisclosed fraudulent stock promotion schemes during December 2024-July 2025. A separate lawsuit targets GRAIL, Inc. (GRAL) with an August 4, 2026 deadline for investors to secure counsel. Both cases allege material misstatements and failure to disclose adverse facts affecting stock prices.

BYAH Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Park Ha Biological Technology Co., Ltd. Class Action

GlobeNewswire Inc. · 8/1/2026, 12:23:00 AM

Robbins LLP announces a securities class action lawsuit against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) for allegedly being subject to a market manipulation and pump-and-dump scheme involving social media misinformation and impersonated financial professionals. The company failed to disclose material risks associated with the scheme. Park Ha's stock surged from $4.00 to $41.49 before collapsing 93% to $2.99 on July 8, 2025, wiping out over $1 billion in market value. The lead plaintiff deadline is September 28, 2026.

Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire Inc. · 7/30/2026, 4:36:00 PM

A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) alleging securities fraud. The complaint claims the company made false and misleading statements, failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation, and intentionally structured its IPO with an extremely low public float to facilitate manipulation. Investors who purchased securities between December 27, 2024 and July 8, 2025 can join the case, with a lead plaintiff deadline of September 21, 2026.

Park Ha Biological Technology (BYAH) Stock Surges Over 41% After Hours: Why Is It Moving?

Benzinga · 6/18/2026, 4:27:05 AM

Park Ha Biological Technology (NASDAQ: BYAH) shares jumped 41.66% to $1.70 in after-hours trading following the closing of a $2.0 million registered direct offering. The stock had dropped 20% during regular trading to $1.20. The company also announced a strategic AI-driven skincare partnership with Star Plus Action. Despite the after-hours surge, BYAH has declined 99.89% over the past 12 months and remains near its annual low, indicating continued investor pressure.

Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering

GlobeNewswire Inc. · 6/12/2026, 6:54:00 PM

Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) announced a registered direct offering of up to 1,133,332 Class A ordinary shares and pre-funded warrants to purchase 200,000 shares at $1.50 per unit, expected to raise approximately $2.0 million. The offering is expected to close on June 15, 2026, with net proceeds designated for general corporate and working capital purposes. D. Boral Capital LLC is serving as the sole placement agent.